Biofrontera Inc.
BFRI
Rank in Stocks
#31546
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Share Price
$0.8232
Last synced: 2026-10-16
Market Cap
$12.23M
Change (1 day)
-2.82%
Change (1 year)
-72.10%
Country
US
Trade Biofrontera Inc. (BFRI)
Category
Healthcare
P/S ratio for Biofrontera Inc. (BFRI)
P/S ratio as of 2026 TTM: 0
According to Biofrontera Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Biofrontera Inc. from 2026 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 10.31 | - |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 2.36 | - |
HK
|
